<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 18 May 2026 13:48:39 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/cancertherapymarkettrend/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Cancer Immunotherapy Market Shares, Strategies and Forecast Worldwide, 2022]]></title><description><![CDATA[The Global Cancer Immunotherapy Market was valued at $45,471 million in 2015, and is projected to reach $117,114 million by 2022, growing at a CAGR of 14.5% from 2016 to 2022. The monoclonal antibodies]]></description><link>http://direct.ecency.com/cancerimmunotherapy/@chemicals/cancer-immunotherapy-market-shares-strategies-and-forecast-worldwide-2022</link><guid isPermaLink="true">http://direct.ecency.com/cancerimmunotherapy/@chemicals/cancer-immunotherapy-market-shares-strategies-and-forecast-worldwide-2022</guid><category><![CDATA[cancerimmunotherapy]]></category><dc:creator><![CDATA[chemicals]]></dc:creator><pubDate>Wed, 15 Jan 2020 12:44:24 GMT</pubDate></item></channel></rss>